TFEB and metabolic syndrome: Studies have shown that dyslipidemia, particularly via oxidized low-density lipoprotein (LDL), disrupts normal autophagy by inhibiting the activity of transcription factor EB (TFEB), resulting in decreased autophagic flux and increased necroptosis in chondrocytes.